68 related articles for article (PubMed ID: 3387519)
1. Haloperidol plasma levels and clinical response: a therapeutic window relationship.
Van Putten T; Marder SR; Mintz J; Poland RE
Psychopharmacol Bull; 1988; 24(1):172-5. PubMed ID: 3387519
[No Abstract] [Full Text] [Related]
2. Review of haloperidol blood level and clinical response: looking through the window.
Volavka J; Cooper TB
J Clin Psychopharmacol; 1987 Feb; 7(1):25-30. PubMed ID: 3546403
[TBL] [Abstract][Full Text] [Related]
3. Blood levels of haloperidol and clinical outcome in schizophrenia.
Doddi S; Rifkin A; Karajgi B; Cooper T; Borenstein M
J Clin Psychopharmacol; 1994 Jun; 14(3):187-95. PubMed ID: 8027415
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of haloperidol and clinical response.
Van Putten T; Marder SR; May PR; Poland RE; O'Brien RP
Psychopharmacol Bull; 1985; 21(1):69-72. PubMed ID: 3920705
[No Abstract] [Full Text] [Related]
5. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
[TBL] [Abstract][Full Text] [Related]
6. Haloperidol plasma and red blood cell levels and clinical antipsychotic response.
Garver DL; Hirschowitz J; Glicksteen GA; Kanter DR; Mavroidis ML
J Clin Psychopharmacol; 1984 Jun; 4(3):133-7. PubMed ID: 6736272
[TBL] [Abstract][Full Text] [Related]
7. Absence of relationship of serum haloperidol concentration and clinical response in chronic schizophrenia: a fixed-dose study.
Bigelow LB; Kirch DG; Braun T; Korpi ER; Wagner RL; Zalcman S; Wyatt RJ
Psychopharmacol Bull; 1985; 21(1):66-8. PubMed ID: 3983341
[No Abstract] [Full Text] [Related]
8. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M
Encephale; 1995; 21(6):417-24. PubMed ID: 8674466
[TBL] [Abstract][Full Text] [Related]
9. Plasma haloperidol levels and clinical response in acute schizophrenia.
Extein I; Augusthy KA; Gold MS; Pottash AL; Martin D; Potter WZ
Psychopharmacol Bull; 1982 Oct; 18(4):156-8. PubMed ID: 7156281
[No Abstract] [Full Text] [Related]
10. Does a therapeutic window for plasma haloperidol exist?: Preliminary Chinese data.
Potkin SG; Shen YC; Zhou DF; Pardes H; Shu L; Phelps B; Poland R
Psychopharmacol Bull; 1985; 21(1):59-61. PubMed ID: 3983339
[No Abstract] [Full Text] [Related]
11. Haloperidol plasma levels and clinical response: basic concepts and clinical data.
Davis JM; Ericksen SE; Hurt S; Chang SS; Javaid JI; Dekirmenjian H; Casper R
Psychopharmacol Bull; 1985; 21(1):48-51. PubMed ID: 3983337
[No Abstract] [Full Text] [Related]
12. Haloperidol: therapeutic window in schizophrenia.
Palao DJ; Arauxo A; Brunet M; Bernardo M; Haro JM; Ferrer J; Gonzalez-Monclus E
J Clin Psychopharmacol; 1994 Oct; 14(5):303-10. PubMed ID: 7806684
[TBL] [Abstract][Full Text] [Related]
13. Plasma haloperidol levels and clinical response: confounding variables.
Mavroidis ML; Garver DL; Kanter DR; Hirschowitz J
Psychopharmacol Bull; 1985; 21(1):62-5. PubMed ID: 3983340
[No Abstract] [Full Text] [Related]
14. [Use of haloperidol in high doses in schizophrenia. Clinical, biochemical and pharmacokinetic study].
Scatton B; Zarifian E; Bianchetti G; Cuche H; Loo H; Morselli PL
Encephale; 1982; 8(1):1-8. PubMed ID: 7094868
[TBL] [Abstract][Full Text] [Related]
15. Beyond the therapeutic window: a case presentation.
Schulz SC; Butterfield L; Garicano M; Narasimhachari N; Friedel RO
J Clin Psychiatry; 1984 May; 45(5):223-5. PubMed ID: 6725212
[TBL] [Abstract][Full Text] [Related]
16. Blood levels of haloperidol in schizophrenic patients.
Shvartsburd A; Dekirmenjian H; Smith RC
J Clin Psychopharmacol; 1983 Feb; 3(1):7-12. PubMed ID: 6833528
[TBL] [Abstract][Full Text] [Related]
17. Haloperidol and thioridazine drug levels and clinical response in schizophrenia: comparison of gas-liquid chromatography and radioreceptor drug level assays.
Smith RC; Baumgartner R; Burd A; Ravichandran GK; Mauldin M
Psychopharmacol Bull; 1985; 21(1):52-8. PubMed ID: 3983338
[No Abstract] [Full Text] [Related]
18. Effect of varying haloperidol plasma levels on negative symptoms in schizophrenia and schizoaffective disorder.
Volavka J; Cooper TB; Czobor P; Meisner M
Psychopharmacol Bull; 1996; 32(1):75-9. PubMed ID: 8927679
[TBL] [Abstract][Full Text] [Related]
19. Haloperidol dose, plasma levels, and clinical response: a double-blind study [proceedings].
Ericksen SE; Hurt SW; Chang S
Psychopharmacol Bull; 1978 Apr; 14(2):15-6. PubMed ID: 349597
[No Abstract] [Full Text] [Related]
20. Plasma haloperidol levels drawn at neuroleptic threshold doses: a pilot study.
McEvoy JP; Stiller RL; Farr R
J Clin Psychopharmacol; 1986 Jun; 6(3):133-8. PubMed ID: 3711363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
